Home> News

  • Capital communities lower risk levels for coronavirus


    Nearly 20 residential communities in Beijing have lowered their risk level for COVID-19 control and prevention as the city has taken effective measures to contain the spread of the outbreak, a senior official said on July 1.

  • Drug regulators crack down on counterfeit and substandard drugs in 2019


    In 2019, drug regulators at all levels in China conscientiously implemented strict requirements on drug safety, carried out supervision and inspection of pharmaceutical manufacturers and distributors, and severely cracked down on illegal manufacturing and sale of counterfeit and substandard drugs.

  • China's first COVID-19 mRNA vaccine approved for clinical trials


    ARCoV, a novel coronavirus Messenger RNA (mRNA) vaccine candidate jointly developed by the People's Liberation Army (PLA) Academy of Military Sciences, Suzhou Abogen Biosciences and Walvax Biotechnology Co., Ltd, was officially approved by the National Medical Products Administration of clinical trial on June 19, according to CCTV's report.

  • China's Hubei clears asymptomatic COVID-19 cases


    No newly confirmed, asymptomatic or suspected cases of COVID-19 were reported in Central China's Hubei province on June 30, the provincial health commission said on July 1.

  • Over one million service workers in Beijing receive COVID-19 tests


    A total of 1.18 million service practitioners from wet markets, restaurants, supermarkets, stores, hair and beauty salons as well as couriers and food delivery personnel in Beijing have received nucleic acid tests for COVID-19, local authorities said on June 29.

  • China develops novel rabies vaccine


    A novel rabies vaccine for humans shows promise in preclinical testing, according to a new study published in the journal EBioMedicine.

< 1 ... 198 199 200